title: Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome.
authors: D
authors: D
authors: Sánchez-Cano
authors: J L
authors: JL
authors: Callejas-Rubio
authors: M A
authors: MA
authors: Lara-Jiménez
authors: M
authors: M
authors: López-Trascasa
authors: M
authors: M
authors: Circadi
authors: N
authors: N
authors: Ortego-Centeno
mesh_terms: D000368:Aged; D000799:Angioedema / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D050718:Complement C1 Inhibitor Protein / Q000032:analysis* / Q000502:physiology; D005260:Female; D006801:Humans; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D050718:Complement C1 Inhibitor Protein; D000069283:Rituximab